1,300
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Antibacterial activity of gold-titanates on Gram-positive cariogenic bacteria

, , , &
Pages 51-58 | Received 09 Mar 2015, Accepted 17 Aug 2015, Published online: 18 Sep 2015

References

  • Hara AT, Zero DT. The caries environment: saliva, pellicle, diet, and hard tissue ultrastructure. Dent Clin North Am. 2010;54(3):455–467
  • Tanzer JM, Livingston J, Thompson AM. The microbiology of primary dental caries in humans. J Dent Educ. 2001;65(10):1028–1037
  • Matsui R, Cvitkovitch D. Acid tolerance mechanisms utilized by Streptococcus mutans. Future Microbiol. 2010;5(3):403–417
  • Takahashi N, Nyvad B. The role of bacteria in the caries process: ecological perspectives. J Dent Res. 2010;90(3):294–303
  • Badet C, Thebaud NB. Ecology of lactobacilli in the oral cavity: a review of literature. Open Microbiol J. 2008;2:38–48
  • Amarnath K, Kumar J, Reddy T, Mahesh V, Ayyappan SR, Nellore J. Synthesis and characterization of chitosan and grape polyphenols stabilized palladium nanoparticles and their antibacterial activity. Colloids Surf B Biointerfaces. 2012;92:254–261
  • Lopes I, Ribeiro R, Antunes FE, Rocha-Santos TAP, Rasteiro MG, Soares AM, Gonçalves F, Pereira R.Toxicity and genotoxicity of organic and inorganic nanoparticles to the bacteria Vibrio fischeri and Salmonella typhimurium. Ecotoxicology. 2012;21(3):637–648
  • Ma S, Izutani N, Imazato S, Chen J, Kiba W, Yoshikawa R, Takeda K, Kitagawa H, Ebisu S. Assessment of bactericidal effects of quaternary ammonium-based antibacterial monomers in combination with colloidal platinum nanoparticles. Dent Mater J. 2012;31(1):150–156
  • Mohanty S, Mishra S, Jena P, Jacob B, Sarkar B, Sonawane A. An investigation on the antibacterial, cytotoxic, and antibiofilm efficacy of starch-stabilized silver nanoparticles. Nanomedicine. 2012;8(6):916–924
  • Allaker RP. The use of nanoparticles to control oral biofilm formation. J Dent Res. 2010;89(11):1175–1186
  • Mohamed Hamouda I. Current perspectives of nanoparticles in medical and dental biomaterials. J Biomed Res. 2012;26(3):143–151
  • Ahn SJ, Lee SJ, Kook JK, Lim BS. Experimental antimicrobial orthodontic adhesives using nanofillers and silver nanoparticles. Dent Mater. 2009;25:206–213
  • Moszner N, Salz U. Recent developments of new components for dental adhesives and composites. Macromol Mater Eng. 2007;292:245–271
  • Hobbs DT, Barnes MJ, Pulmano RL, Marshall KM, Edwards TB, Bronikowski MG, Fink SD. Strontium and actinide separations from high level nuclear waste solutions using monosodium titanate 1. Simulant testing. Separ Sci Technol. 2005;40(15):3093–3111
  • Hobbs DT. The properties and uses of sodium titanates and peroxotitanates. J S C Acad Sci. 2011;9(1):20–24
  • Nyman M, Hobbs DT. A family of peroxo-titanate materials tailored for optimal strontium and actinide sorption. Chem Mater. 2006;18:6425–6435
  • Davis RR, Hobbs DT, Khashaba R, Sehkar P, Seta FN, Messer RLW, Lewis JB, Wataha JC. Titanate particles as agents to deliver gold compounds to fibroblasts and monocytes. J Biomed Mater Res A. 2009;93A(3):864–869
  • Wataha JC, Hobbs DT, Lockwood PE, Davis RR, Elvington MC, Lewis JB, Messer RLW. Peroxotitanates for biodelivery of metals. J Biomed Mater Res B Appl Biomater. 2009;91B(2):489–496
  • Wataha JC, Hobbs DT, Wong JJ, Dogan S, Zhang H, Chung KH, Elvington MC. Titanates deliver metal ions to human monocytes. J Mater Sci Mater Med. 2010;21(4):1289–1295
  • Chung WO, Wataha JC, Hobbs DT, An J, Wong JJ, Park CH, Dogan S. Elvington MC. Rutherford RB. Peroxotitanate- and monosodium metal-titanate compounds as inhibitors of bacterial growth. J Biomed Mater Res A. 2011;97A(3):348–354
  • Elvington MC, Tosten M, Taylor-Pashow KML, Hobbs DT. Synthesis and characterization of nanosize sodium titanates. J Nanopart Res. 2012;14:1114
  • Zhao Y, Tian Y, Cui Y, Liu W, Ma W, Jiang X. Small molecule-capped gold nanoparticles as potent antibacterial agents that target Gram-negative bacteria. J Am Chem Soc. 2010;132(35):12349–12356
  • Brown AN, Smith K, Samuels TA, Lu J, Obare SO, Scott ME. Nanoparticles functionalized with ampicillin destroy multiple-antibiotic-resistant isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and methicillin-resistant Staphylococcus aureus. Appl Environ Microbiol. 2012;78(8):2768–2774
  • Zhou Y, Kong Y, Kandu S, Cirillo JD, Liang H. Antibacterial activities of gold and silver nanoparticles against Escherichia coli and bacillus Calmette-Guerin. J Nanobiotechnology. 2012;10–19
  • Boisselier E, Astruc D. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem Soc Rev. 2009;38(6):1759
  • Kovvuru P, Mancilla PE, Shirode AB, Murray TM, Begley TJ, Reliene R. Oral ingestion of silver nanoparticles induces genomic instability and DNA damage in multiple tissues. Nanotoxicology. 2015;9(2):162–71
  • Davis RR, Lockwood PE, Hobbs DT, Messer RL, Price RJ, Lewis JB, et al. In vitro biological effects of sodium titanate materials. J Biomed Mater Res B Appl Biomater. 2007;83(2):505–511
  • Drury JL, Jang Y, Taylor-Pashow KM, Elvington M, Hobbs DT, Wataha JC. In vitro biological response of micro- and nano-sized monosodium titanates and titanate-metal compounds. J Biomed Mater Res B Appl Biomater. [E-pub ahead of print May 13, 2014] In press
  • Hernández-Sierra JF, Ruiz F, Pena DC, Martínez-Gutiérrez F, Martínez AE, Guillén Ade J, et al. The antimicrobial sensitivity of Streptococcus mutans to nanoparticles of silver, zinc oxide, and gold. Nanomedicine. 2008;4(3):237–240
  • Lokina S, Suresh R, Giribabu K, Stephen A, Lakshmi Sundaram R, Narayanan V. Spectroscopic investigations, antimicrobial, and cytotoxic activity of green synthesized gold nanoparticles. Spectrochim Acta A Mol Biomol Spectrosc. 2014;129C:484–490
  • Wang S, Lawson R, Ray PC, Yu H. Toxic effects of gold nanoparticles on Salmonella typhimurium bacteria. Toxicol Ind Health. 2011;27(6):547–554
  • Cui W, Li J, Zhang Y, Rong H, Lu W, Jiang L. Effects of aggregation and the surface properties of gold nanoparticles on cytotoxicity and cell growth. Nanomedicine. 2012;8(1):46–53
  • Pelgrift RY, Friedman AJ. Nanotechnology as a therapeutic tool to combat microbial resistance. Adv Drug Deliv Rev. 2013;65:1803–1815